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Vibrio vulnificus is a heterogeneous species that comprises strains virulent and avirulent for humans and
fish, and it is grouped into three biotypes. In this report, we describe a PCR-based methodology that allows
both the species identification and discrimination of those isolates that could be considered dangerous to
public health. Discrimination is based on the amplification of a variable region located within the gene pilF,
which seems to be associated with potential human pathogenicity, regardless of the biotype of the strain.
Vibrio vulnificus is a marine species from warm and tropical
ecosystems that can be found associated with the surface of
algae or the external and internal mucous surfaces of aquatic
animals (16). The species is present in high numbers in filtering
organisms, such as oysters, especially in warmer months (16).
V. vulnificus is highly heterogeneous and comprises strains
virulent and avirulent for humans, shrimp, and fish, and it is
grouped into three biotypes (5, 16, 24). Biotypes 1 and 3 are
opportunistic human pathogens, while biotype 2 is pathogenic
for aquatic animals such as eels (5, 16, 24). This biotype com-
prises a zoonotic serovar (serovar E) also involved in human
infections (2).
V. vulnificus human infection follows the ingestion of under-
cooked seafood, particularly raw oysters, or the exposure of
wounds to seawater or marine animals (16). The ingestion of V.
vulnificus by healthy individuals can result in gastroenteritis,
but when the bacterium is ingested by individuals with under-
lying chronic disease, particularly liver disease, the infection
can develop into septic shock, rapidly followed by death with a
probability of 50% (16). Wound infections by V. vulnificus can
progress rapidly to necrotizing fasciitis, requiring fasciotomies
and debridement (16), and in individuals with underlying
chronic disease, it may lead to secondary septicemia with a
course identical to that of primary septicemia (16).
The recent description of a plasmid encoding the virulence
genes essential for fish vibriosis (13) facilitated the design of a
PCR protocol for the rapid identification of the strains that
pose a risk for fish culture (21). In contrast, the genetic basis of
human infections is poorly understood, thereby inhibiting the
design of methods targeting specific virulence genes to identify
the strains posing a public health hazard, especially in oysters
for human consumption. Nevertheless, several genotyping sys-
tems based on polymorphisms in some loci, such as 16S rRNA
or the vcg (virulence correlated gene) locus, apparently divide
V. vulnificus populations into two genotypes, one associated
with an environmental origin and the other with a clinical
(human) one, and they have been proposed as a means to
distinguish the strains with human pathogenic potential (15,
19). However, although these systems work well with biotype 1
strains, they fail with biotype 2 and 3 isolates of human origin,
which present an environmental genotype (22). This last find-
ing suggests that new systems should be designed taking into
account the entire genetic diversity of human pathogenic iso-
lates.
The present work arises from a previous multilocus se-
quence typing analysis on the genetic diversity of the species in
which four housekeeping genes and three virulence-associated
genes were partially sequenced in a collection of more than 100
strains belonging to the three biotypes isolated worldwide (20).
Results with a selection of these isolates revealed that the
population apparently was divided into two groups in terms of
sequence variability for the fragment of the pilF gene. One
group comprised most of the human clinical strains, regardless
of the biotype, together with some environmental strains, while
the other group encompassed most of the environmental
strains. PilF is a protein required for pilus-type IV assembly
whose mutation in some bacterial pathogens implies attenu-
ated virulence for mice (6). Taking these results into account,
the objective of the present work was to develop a PCR meth-
odology based on pilF variability that could identify the isolates
that potentially are dangerous to public health, under the hy-
pothesis that differences in the pilF gene in V. vulnificus are
related to human pathogenic potential.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The V. vulnificus strains used in this
study and their characteristics, including the genotyping, are listed in Table 1.
Strains were routinely grown in tryptone soy broth or agar plus 5 g/liter NaCl
(TSB-1 or TSA-1; Pronadisa, Spain) at 28°C for 24 h. For genomic DNA extrac-
tion, bacteria were grown overnight with shaking at 28°C. The strains were
maintained both as lyophilized stocks and as frozen stocks at 80°C in marine
broth (Difco) plus 20% (vol/vol) glycerol.
DNA isolation and manipulation. For DNA sequencing, genomic DNA was
extracted according to the Mini-Prep protocol (4). For PCR determinations
from overnight cultures, DNA was extracted by the boiling method (8).
Briefly, the samples were boiled for 10 min and supernatants, obtained after
centrifugation, either were directly used as DNA samples (bacterial cultures)
or were subjected to extraction with phenol-chlorophorm, precipitation with
ethanol, and suspension in 100 l of Tris-HCl 10 mM. All DNA samples were
stored at 20°C until use.
Sequence analysis. Primers to amplify the full-length pilF gene were designed
from the published sequences of strains YJ016 and CMCP6, both from biotype
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TABLE 1. V. vulnificus strains used in the study: source, biotype, genotype, serovar, and PCR results
Strain(s) Biotype/serovara Origin
Genotypingb Country of
isolation
PCR Human serum
resistancevcg 16S rRNA Vvha Vvpdh
ATCC33816, CECT 5164, CECT 5168,
CECT 5169,
Bt1/NT Human blood C B United States   
CECT 529Td Bt1/NT Human blood E A United States   
CECT 5166 Bt1/NT Wound infection E B United States   
CECT 5165d Bt1/NT Seawater E A United States   
E4 Bt1/NT Seafood C B United States   
JEc Bt1/NT Seafood E B United States   
MLT364, MLT362 Bt1/NT Environmental C B United States   
VV1003c, Bt1/NT Environmental C B United States   
VV352c,d, VV425c Bt1/NT Environmental E A United States   
MLT404d, MLT406d Bt1/NT Environmental E A United States   
V4d Bt1/NT Human blood C B Australia   
CS9133 Bt1/NT Human blood C B South Korea   
CECT 5167, N87, KH03 Bt1/NT Human blood C B Japan   
YN03 Bt1/NT Human blood E A Japan   
L49 Bt1/NT Brackish water E A Japan   
YJ106 Bt1/NT Human blood C B Taiwan   
CG118 Bt1/NT Seawater C B Taiwan   
CG100d Bt1/NT Oyster C B Taiwan   
CG106 Bt1/NT Oyster E A Taiwan   
CG110, CG111 Bt1/NT Seawater C B Taiwan   
CECT 4867 Bt1/NT Diseased eel E A Sweden   
94-9-118 Bt1/NT Human expectoration E A Denmark   
94-9-130 Bt1/NT Water E A Denmark   
94-9-119 Bt1/NT Human wound E A Denmark   
A2, A4, A5, A6, A7, PD-1, PD-3, PD-
5, PD-12, V1
Bt1/NT Eel tank water E A Spain   
PD-2-66 Bt1/NT Eel tank water E B Spain   
CECT 4606d Bt1/NT Healthy eel E A Spain   
Riu-1 Bt1/NT Seawater E A Spain   
Riu-3 Bt1/NT Seawater E AB Spain   
94385d Bt1/NT Leg wound E B Spain   
CECT 4608d Bt1/NT Eel farm water C B Spain   
CECT 5768, A13, A21, A22, CECT
5689, CECT 5769, A15, A16, A17,
A18, CECT 5198, CECT 5343, A10,
A11, A14d
Bt2/SerA Diseased eel E A Spain   
4/7/17, 4/7/19, Bt2/SerA Diseased eel E A Denmark   
21B, 22, 26, 27, 21A Bt2/SerA Diseased eel ND ND Denmark   
CECT 4864, CECT 4999d, CECT
4605, CECT 4607, CECT 4604d,
CECT 4602, CECT 4603,
CECT 4601
Bt2/SerE Diseased eel E A Spain   
PD-2-47, PD-2-50, PD-2-51, PD-2-55,
PD-2-56, CECT 5763
Bt2/SerE Eel tank water E A Spain   
C1, CECT 5762 Bt2/SerE Healthy eel E A Spain   
Riu-2 Bt2/SerE Seawater E A Spain   
CIP8190 Bt2/SerE Human blood E A France   
CECT 4868 Bt2/SerE Diseased eel E A Norway   
90-2-11 Bt2/SerE Diseased eel E A Denmark   
4-8-112 Bt2/SerE Human wound E A Denmark   
94-9-123 Bt2/SerE Seawater E A Denmark   
CCUG38521 Bt2/SerE Human blood ND ND Sweden   
O¨122 Bt2/SerE Diseased eel ND ND Sweden   
CECT 4866 Bt2/SerE Human blood E A Australia   
CECT 4865 Bt2/SerE Diseased shrimp E A Taiwan   
UE516 Bt2/SerE Diseased eel E A Taiwan   
CECT 898, CECT 897, CECT 4174,
CECT 4862
Bt2/SerE Diseased eel E A Japan   
95-8-161d, 95-8-162d Bt2/SerI Diseased eel E A Denmark   
CECT 4869d Bt2/SerI Diseased eel E A Belgium   
95-8-7d Bt2/SerI Diseased eel E A Denmark   
95-8-6d Bt2/SerI Diseased eel E A Denmark   
97, 162d, 11028d, vv12, vv32 Bt3/SerO Diseased human E AB Israel   
V. alginolyticus CECT 521T   Not tested
V. anguillarum CECT 522T   Not tested
V. cholerae CECT 514T   Not tested
V. natriegens CECT   Not tested
V. parahaemolyticus CECT 511T   Not tested
a Bt, biotype; NT, nontypeable; SerE, serovar E; SerA, serovar A; SerI, serovar I; SerO, serovar O.
b Genotyping data are from Sanjuan et al. (20); E type and C type are according to Rosche et al. (19); A type, B type, and AB type are according to Lee et al. (13).
ND, not done.
c Translucent strain.
d Strains used for whole pilF gene sequencing.
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1 (Table 2) (7, 12), and were used with 20 strains representative of the genetic
variability of the species (Table 1). The sequences were aligned with AlignX
(Invitrogen) and were compared by using the maximum likelihood (ML) ap-
proach implemented in Modeltest V3.7 (17). Likelihood scores for each model
for nucleotide substitution were estimated with PAUP*4.0b10, and the best
model was determined using the Akaike information criterion (AIC) (1). ML
phylogenetic trees were obtained with PHYML 2.4.4 (10) using the previously
determined models of nucleotide substitution, and support for the nodes was
evaluated by bootstrapping with 1,000 replicates. The 20 sequences were sub-
mitted to GenBank.
Multiplex PCR design. The alignment of the sequences showed a differential
region of 34 nucleotides that is present in the strains isolated from humans and
the strain belonging to the zoonotic serovar (Fig. 1). This region was used as a
reverse primer to amplify a 338-bp fragment of pilF, which hypothetically is
present only in the isolates endangering public health. Table 2 shows the Vvpdh
(for V. vulnificus potentially dangerous for humans) primer set. A second primer
set was included to amplify a fragment of 521 bp of the cytolysin gene vvhA,
which is species specific (11) (Table 2). PCR was performed in 50-l reaction
volumes that contained 0.2 mM Vvha forward and reverse primers, 0.4 mM
Vvpdh forward and reverse primers, 1.5 U of Taq DNA polymerase (GoTaq; 5
U/l; Promega), 10 l of 5 Taq reaction buffer (Gotaq Green; Promega), 1.125
mM MgCl2, 0.65 mM deoxynucleoside triphosphate (dNTP) mix (Promega) and
2 l of DNA crude extracts. The PCR was performed in a Techne thermocycler
(TC-412). The reaction started with 10 min of denaturation at 94°C and was
followed by 45 cycles of 40 s of denaturation at 94°C, 45 s of annealing at 54°C,
and 45 s of extension at 72°C. An additional extension at 72°C for 10 min
completed the reaction. The detection limit of the PCR in phosphate-buffered
saline–1% NaCl (PBS-1) was evaluated by extracting DNA from 10-fold serial
dilutions of V. vulnificus in PBS-1 (108 to 101 CFU/ml) and subjecting the
samples to the PCR.
Mice virulence. The virulence potential for humans was tested in BALB/c mice
of 20 g of average weight (5 to 6 weeks old) pretreated with Desferal (Sigma)
(iron-overloaded mouse model) according to previously published procedures
(3). To this end, groups of six animals were injected intraperitoneally (i.p.) with
10-fold serial bacterial dilutions of V. vulnificus in PBS-1 (0.2 ml per mouse), and
mortalities were recorded daily for 1 week and considered only if the bacteria
were isolated in pure culture from internal organs. The 50% lethal dose (LD50)
was calculated by the Reed and Muench method (18). Appropriate controls for
each experiment also were included (mice inoculated with PBS-1 and mice
inoculated with Desferal) (3).
Serum resistance. The bacterial resistance to human serum (male AB; Sigma-
Aldrich, Spain), was assessed in 96 microwell plates by mixing 100 l of a
bacterial suspension in PBS-1 containing 104 CFU per ml with 100 l of fresh
human serum. The mixtures were incubated at 37°C for 24 h, and aliquots were
removed at 0, 1, 3, 9 and 24 h postincubation for bacterial counts on TSA-1 plates
by drop-plate methodology. Experiments were done in triplicate. A strain was
considered resistant if the cell survival percentage was higher than or equal to
100%  20% after 24 h of incubation. The strains CECT 4604 (formerly E86)
and CECT 4606 (formerly E109), which are highly resistant and sensitive to
human serum, respectively, were used as controls (3).
Nucleotide sequence accession numbers. The 20 sequences determined in the
course of this work were submitted to GenBank under accession numbers
FJ756476 to FJ756489 and FJ899603 to FJ899608.
RESULTS
We analyzed the sequence variability of the full-length pilF
gene in 20 V. vulnificus strains from different biotypes and
origins, thus trying to cover most of the genetic diversity of the
species (Table 1). The ML tree grouped the human isolates of
biotypes 1 and 3 together with isolates belonging to the zoo-
notic serovar of V. vulnificus and some environmental isolates
TABLE 2. Primers used in this study
Primer Sequence Productsize (bp) Target Utility
VvhaF CCGCGGTACAGGTTGGCGC 521 Hemolysin/cytolisin gene V. vulnificus-specific sequence
VvhaR CGCCACCCACTTTCGGGCC
PilFF CGATTGGTAGGCAATAGAC 917 pilF Primers to sequence pilF gene
PilFR GCAACTCAACCTCAAGACG
VvpdhF TGTCGGTGAAAACGGCAAAGCTG 338 pilF V. vulnificus strains potentially dangerous for humans
VvpdhR GGTATCGATTTCCAACTTAGCGA
GGTTGAGCACC
FIG. 1. Alignment of a segment of the sequenced pilF genes showing the region used for the design of the primer VvpdhR.
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(Fig. 2). Part of the pilF polymorphism resided in a variable
region of 34 nucleotides, which was identified after sequence
alignment (Fig. 1). This region was used as the PCR reverse
primer (VvpdhR) to amplify a pilF fragment of 338 bp in the
isolates of the species believed to be dangerous to public
health, under the hypothesis that all of them shared this frag-
ment. The primers VvpdhR and VvpdhF were combined with
a species-specific primer, and the specificity of the multiplex
PCR was tested on a collection of 112 V. vulnificus strains
belonging to all three biotypes, which were recovered world-
wide from environmental and clinical (human and animal)
sources, together with five strains of other Vibrio species (Table
1). As expected, no amplification product was obtained from
the other Vibrio species, whereas all V. vulnificus strains gave
the species-specific PCR product (Table 1, Fig. 3). All of the V.
vulnificus human isolates of biotype 1 amplified with the Vvpdh
primers, with the exception of the type strain of the species
(CECT 529T) (Table 1, Fig. 3). This isolate was confirmed to
lack human virulence potential after determining its virulence
degree in iron-overloaded mice (50% LD50  10
8 CFU per
mouse) and its survival in human serum (0% survival after 24 h
of incubation). In addition, we found positive results from
some biotype 1 environmental isolates (Table 1). Since the
species is an autochthonous member of the marine ecosystem
where virulent and avirulent strains can coexist, the possibility
that these Vvpdh-positive biotype 1 environmental isolates
could be pathogenic for humans was evaluated by assessing
their susceptibility to human serum. Results of human serum
resistance tests showed that approximately 80% of these iso-
lates resisted the bactericidal activity of human serum (survival
rate of more than 90%  10%) (Table 1, Fig. 2). The serum-
sensitive isolates either lacked capsule or were less capsulated,
since they developed translucent colonies on agar plates (data
not shown).
In the case of biotype 2, all isolates belonging to the zoonotic
serovar positively amplified with the Vvpdh primers regardless
of their origin, while the isolates belonging to serovar A did
not, and the isolates belonging to serovar I gave variable results
(Table 1, Fig. 3). All of the biotype 2 isolates that were positive
for Vvpdh resisted the bactericidal action of human serum
(survival rate of 90%  10%) (Table 1). This result is in
agreement with previous studies, demonstrating that biotype 2
is formed by three distinct clonal complexes (20), one of which
is able to infect humans (2), another is unable to do so (9), and
the third (a minority) has yet to be studied. Finally, all biotype
3 strains, all of human origin, amplified with the Vvpdh prim-
ers and resisted the bactericidal activity of human serum (Ta-
ble 1).
FIG. 2. Maximum likelihood phylogenetic tree of 20 V. vulnificus isolates obtained from the alignment of the pilF gene. Isolates that resisted
the action of the human sera are shown in boldface. A circle represents Vvpdh-positive isolates.
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DISCUSSION
In a previous work on multilocus sequence typing (20), we
found evidence that the human isolates of V. vulnificus of the
three biotypes could be separated from the others on the basis
of variations in the pilF gene sequence. This result leads us to
hypothesize that pilF is a good genetic marker for human
virulence potential in this species. To test this hypothesis, we
sequenced the entire gene in 20 human and nonhuman iso-
lates, and the sequences were analyzed. The ML tree grouped
the human isolates together with those of the zoonotic serovar,
and the sequence alignment identified a variable region that
facilitated the design of a primer set. A multiplex PCR method
was developed and tested on a wide range of V. vulnificus
isolates that were representative of the genetic diversity of the
species to assess its ability to differentiate V. vulnificus isolates
that pose a risk to public health. All of the V. vulnificus human
isolates of the three biotypes gave the expected amplification
products, with the exception of the type strain of the species
(CECT 529T), a blood isolate lacking the Vvpdh band. Despite
its human clinical origin, this strain proved avirulent for iron-
overloaded mice, the animal model used to predict human
virulence in V. vulnificus, and to be sensitive to human serum.
The type strain of the species was isolated from human blood
in the 1970s and has been kept under laboratory conditions
since then. It is possible that spontaneous mutations have af-
fected this gene, with some diminishing its virulence. Alterna-
tively, it is possible that this strain was isolated from an immu-
nosuppressed host and was weakly virulent in origin. In fact,
this isolate was grouped together with environmental strains by
other typing methods for V. vulnificus, such as typing the vcg
locus or 16S rRNA (Table 1 and reference 22). Thus, the
negative result obtained by PCR for the type strain of the
species does not necessarily invalidate the usefulness of this
PCR as a method to discriminate strains that may be danger-
ous to public health. Furthermore, a number of environmental
biotype 1 and 2 isolates also gave a positive result for both
primers in the PCR. Most of these isolates were resistant to
human serum and, therefore, seem to belong to the group of V.
vulnificus isolates dangerous to public health. The serum sen-
sitivity of the remaining Vvpdh-positive environmental isolates
could be related to the lack of capsule, as those strains devel-
oped translucent colonies on agar plates. In fact, capsule is
reported to be essential for V. vulnificus resistance to human
serum and virulence (3, 14, 23). Thus, the encapsulated envi-
ronmental Vvpdh-positive isolates could constitute a risk to
public health. As expected, no correspondences between the
results in the Vvpdh PCR and vcg/rRNA typing were found
(Table 1). In this sense, although 91% of the Vvpdh-negative
strains showed the profile usually associated with nondanger-
ous strains (vcg E type and rRNA A type [15, 19, 25]), 62% of
the Vvpdh-positive strains also were vcg E type and rRNA A
type (Table 1). This result is due mainly to the biotype 2 and 3
isolates that were positive for the Vvpdh PCR.
In conclusion, two genotypes can be identified within V.
vulnificus strains on the basis of pilF variability. One encom-
passes most of the strains that potentially are dangerous for
public health (Vvpdh positive) regardless of their biotype, and
the other comprises all other strains (Vvpdh negative). PilF is
a protein required for pilus type IV assembly whose mutation
in other bacterial pathogens is involved in attenuated virulence
for mice (6). The exact role of pilF in virulence for mice/
humans in V. vulnificus strains has yet to be determined. Ad-
ditional studies using natural samples of molluscan shellfish
would clarify the potential of multiplex PCR for V. vulnificus
risk assessment.
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